Geron Corporation
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, …
Biotechnology
US, Foster City [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Geron Corporation can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDGeron Corporation can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Geron Corporation.
If you want to see a demo, head over to the financial segments of AAPL